1. Home
  2. SHPH vs NVVE Comparison

SHPH vs NVVE Comparison

Compare SHPH & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHPH
  • NVVE
  • Stock Information
  • Founded
  • SHPH 2012
  • NVVE 1996
  • Country
  • SHPH United States
  • NVVE United States
  • Employees
  • SHPH N/A
  • NVVE N/A
  • Industry
  • SHPH Biotechnology: Pharmaceutical Preparations
  • NVVE Oil Refining/Marketing
  • Sector
  • SHPH Health Care
  • NVVE Energy
  • Exchange
  • SHPH Nasdaq
  • NVVE Nasdaq
  • Market Cap
  • SHPH 2.7M
  • NVVE 2.8M
  • IPO Year
  • SHPH 2022
  • NVVE N/A
  • Fundamental
  • Price
  • SHPH $0.64
  • NVVE $2.82
  • Analyst Decision
  • SHPH
  • NVVE
  • Analyst Count
  • SHPH 0
  • NVVE 0
  • Target Price
  • SHPH N/A
  • NVVE N/A
  • AVG Volume (30 Days)
  • SHPH 74.0K
  • NVVE 11.5K
  • Earning Date
  • SHPH 11-13-2024
  • NVVE 11-12-2024
  • Dividend Yield
  • SHPH N/A
  • NVVE N/A
  • EPS Growth
  • SHPH N/A
  • NVVE N/A
  • EPS
  • SHPH N/A
  • NVVE N/A
  • Revenue
  • SHPH N/A
  • NVVE $5,144,831.00
  • Revenue This Year
  • SHPH N/A
  • NVVE $200.61
  • Revenue Next Year
  • SHPH N/A
  • NVVE $109.43
  • P/E Ratio
  • SHPH N/A
  • NVVE N/A
  • Revenue Growth
  • SHPH N/A
  • NVVE N/A
  • 52 Week Low
  • SHPH $0.61
  • NVVE $2.82
  • 52 Week High
  • SHPH $4.94
  • NVVE $72.70
  • Technical
  • Relative Strength Index (RSI)
  • SHPH 27.09
  • NVVE 30.04
  • Support Level
  • SHPH $0.61
  • NVVE $3.31
  • Resistance Level
  • SHPH $0.79
  • NVVE $3.69
  • Average True Range (ATR)
  • SHPH 0.06
  • NVVE 0.22
  • MACD
  • SHPH 0.00
  • NVVE -0.05
  • Stochastic Oscillator
  • SHPH 12.15
  • NVVE 0.00

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.

About NVVE Nuvve Holding Corp.

Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.

Share on Social Networks: